CEP & EU-DMF API List
A focused list of APIs with CEP and/or EU-DMF documentation indicated in the current catalogue.
Download PDF ↓A curated portfolio of active pharmaceutical ingredients for pharmaceutical manufacturers across Portugal, Spain and the European Union.
Request Documentation →A focused list of APIs with CEP and/or EU-DMF documentation indicated in the current catalogue.
Download PDF ↓The complete portfolio with CAS numbers and current CEP, EU-DMF, US-DMF, GMP, in-progress or documentation-on-request status.
Download PDF ↓Injectable anti-inflammatory & immunosuppressant corticosteroid
Oral / ophthalmic corticosteroid; broad anti-inflammatory use
Injectable / oral corticosteroid; hospital anti-inflammatory
Adrenal insufficiency; systemic & topical corticosteroid
Topical / nasal corticosteroid
Oral-contraceptive estrogen backbone
Luteal support & HRT; largest-volume hormone
Appetite stimulant; oncology cachexia
Anti-androgen; acne, prostate, contraception
Oral progestogen (luteal support); high-value
Non-depolarising neuromuscular blocker (anaesthesia)
Mineralocorticoid antagonist (heart failure, hypertension)
119 results
Systemic, injectable & ophthalmic
| API | CAS No. | Therapeutic Application | Standard / Grade | Documentation |
|---|---|---|---|---|
| Dexamethasone Sodium Phosphate | 2392-39-4 | Injectable anti-inflammatory & immunosuppressant corticosteroid | Ph. Eur. | CEPEU-DMFUS-DMF |
| Prednisolone | 50-24-8 | Oral / ophthalmic corticosteroid; broad anti-inflammatory use | Ph. Eur. | CEPEU-DMFUS-DMF |
| Prednisone | 53-03-2 | Oral corticosteroid & immunosuppressant | Ph. Eur. | CEPEU-DMFUS-DMF |
| Methylprednisolone | 83-43-2 | Injectable / oral corticosteroid; hospital anti-inflammatory | Ph. Eur. | CEPEU-DMFUS-DMF |
| Hydrocortisone | 50-23-7 | Adrenal insufficiency; systemic & topical corticosteroid | Ph. Eur. | CEPEU-DMFUS-DMF |
| Prednisone Acetate | 125-10-0 | Corticosteroid ester; oral anti-inflammatory | Ph. Eur. | CEPEU-DMFUS-DMF |
| Dexamethasone | 50-02-2 | High-volume corticosteroid; anti-inflammatory / oncology support | Ph. Eur. | US-DMF |
Topical corticosteroids & anti-androgens
| API | CAS No. | Therapeutic Application | Standard / Grade | Documentation |
|---|---|---|---|---|
| Betamethasone Valerate | 2152-44-5 | Topical corticosteroid | Ph. Eur. | US-DMF |
| Mometasone Furoate | 83919-23-7 | Topical / nasal corticosteroid | Ph. Eur. | CEP in progress |
| Mometasone Furoate Monohydrate | 141646-00-6 | Aqueous nasal-spray corticosteroid form | In-house | CEP in progress |
| Hydrocortisone Butyrate | 13609-67-1 | Topical corticosteroid ester | Ph. Eur. | CEP in progress |
| Clascoterone | 19608-29-8 | Topical anti-androgen for acne (novel, high-value) | In-house | US-DMF |
Inhaled & nasal therapies
| API | CAS No. | Therapeutic Application | Standard / Grade | Documentation |
|---|---|---|---|---|
| Tiotropium Bromide | 136310-93-5 | Long-acting anticholinergic bronchodilator (COPD) | Ph. Eur. | US-DMF |
HRT & contraceptive estrogens
| API | CAS No. | Therapeutic Application | Standard / Grade | Documentation |
|---|---|---|---|---|
| Ethinyl Estradiol | 57-63-6 | Oral-contraceptive estrogen backbone | Ph. Eur. | CEPEU-DMFUS-DMF |
| Estradiol Hemihydrate | 35380-71-3 | Core HRT estrogen (menopause) | Ph. Eur. | CEPEU-DMFUS-DMF |
| Estradiol Valerate | 979-32-8 | HRT & injectable estrogen ester | Ph. Eur. | CEPEU-DMF |
Contraceptive & HRT progestins
| API | CAS No. | Therapeutic Application | Standard / Grade | Documentation |
|---|---|---|---|---|
| Progesterone | 57-83-0 | Luteal support & HRT; largest-volume hormone | Ph. Eur. | CEPEU-DMFUS-DMF |
| Megestrol Acetate | 595-33-5 | Appetite stimulant; oncology cachexia | Ph. Eur. | CEPEU-DMFUS-DMF |
| Cyproterone Acetate | 427-51-0 | Anti-androgen; acne, prostate, contraception | Ph. Eur. | CEPEU-DMF |
| Norethisterone | 68-22-4 | Contraceptive & HRT progestin | Ph. Eur. | CEPEU-DMF |
| Dydrogesterone | 152-62-5 | Oral progestogen (luteal support); high-value | Ph. Eur. | CEP in progressEU-DMF |
| Levonorgestrel | 797-63-7 | Contraceptive & emergency contraception progestin | Ph. Eur. | CEP in progressUS-DMF |
| Mifepristone | 84371-65-3 | Progesterone-receptor modulator | Ph. Eur. | CEP in progressEU-DMFUS-DMF |
| Medroxyprogesterone Acetate | 71-58-9 | Depot contraceptive; oncology | Ph. Eur. | CEP in progressUS-DMF |
Testosterone & esters
| API | CAS No. | Therapeutic Application | Standard / Grade | Documentation |
|---|---|---|---|---|
| Testosterone | 58-22-0 | Testosterone-replacement therapy (TRT) | Ph. Eur. | US-DMF |
| Testosterone Undecanoate | 5949-44-0 | Long-acting TRT ester | Ph. Eur. | US-DMF |
| Testosterone Enanthate | 315-37-7 | Core injectable TRT ester | Ph. Eur. | US-DMF |
| Testosterone Cypionate | 58-20-8 | Injectable TRT ester | Ph. Eur. | US-DMF |
| Testosterone Propionate | 57-85-2 | Short-acting TRT ester | Ph. Eur. | US-DMF |
| Testosterone Decanoate | 5721-91-5 | Component of mixed-ester TRT | In-house | US-DMF |
| Testosterone Tridecanoate | 488836-58-4 | Long-acting TRT ester | In-house | US-DMF |
Neuromuscular blockers & reversal
| API | CAS No. | Therapeutic Application | Standard / Grade | Documentation |
|---|---|---|---|---|
| Rocuronium Bromide | 119302-91-9 | Non-depolarising neuromuscular blocker (anaesthesia) | Ph. Eur. | CEPEU-DMFUS-DMF |
| Vecuronium Bromide | 50700-72-6 | Non-depolarising neuromuscular blocker | Ph. Eur. | US-DMF |
Statins, anticoagulants, antihypertensives
| API | CAS No. | Therapeutic Application | Standard / Grade | Documentation |
|---|---|---|---|---|
| Eplerenone | 107724-20-9 | Mineralocorticoid antagonist (heart failure, hypertension) | — | CEPEU-DMF |
| Rosuvastatin Calcium | 147098-20-2 | Statin; hypercholesterolaemia | — | Docs on request |
| Atorvastatin Calcium | 134523-03-8 | Statin; hypercholesterolaemia | — | Docs on request |
| Apixaban | 503612-47-3 | Direct factor-Xa anticoagulant | — | Docs on request |
| Rivaroxaban | 366789-02-8 | Direct factor-Xa anticoagulant | — | Docs on request |
DPP-4 & SGLT2 inhibitors
| API | CAS No. | Therapeutic Application | Standard / Grade | Documentation |
|---|---|---|---|---|
| Sitagliptin Phosphate Monohydrate | 654671-77-9 | DPP-4 inhibitor (type-2 diabetes) | — | Docs on request |
| Linagliptin | 668270-12-0 | DPP-4 inhibitor (type-2 diabetes) | — | Docs on request |
| Alogliptin Benzoate | 850649-62-6 | DPP-4 inhibitor (type-2 diabetes) | — | Docs on request |
| Empagliflozin | 864070-44-0 | SGLT2 inhibitor (type-2 diabetes, HF) | — | Docs on request |
| Dapagliflozin Propanediol | 960404-48-2 | SGLT2 inhibitor (type-2 diabetes, HF, CKD) | — | Docs on request |
| Canagliflozin Monohydrate | 1809403-05-1 | SGLT2 inhibitor (type-2 diabetes) | — | Docs on request |
Antidepressants & neurology
| API | CAS No. | Therapeutic Application | Standard / Grade | Documentation |
|---|---|---|---|---|
| Escitalopram Oxalate | 219861-08-2 | SSRI antidepressant | — | Docs on request |
| Duloxetine Hydrochloride | 136434-34-9 | SNRI antidepressant / neuropathic pain | — | Docs on request |
| Fingolimod Hydrochloride | 162359-56-0 | Multiple-sclerosis immunomodulator | — | Docs on request |
| Brexanolone | 516-54-1 | Postpartum-depression neuroactive steroid | — | US-DMF |
PPIs & acid blockers
| API | CAS No. | Therapeutic Application | Standard / Grade | Documentation |
|---|---|---|---|---|
| Esomeprazole Magnesium Dihydrate | 217087-10-0 | Proton-pump inhibitor (GERD) | — | Docs on request |
| Vonoprazan Fumarate | 1260141-27-2 | Potassium-competitive acid blocker | — | Docs on request |
Antibacterial, antifungal, antimalarial
| API | CAS No. | Therapeutic Application | Standard / Grade | Documentation |
|---|---|---|---|---|
| Moxifloxacin Hydrochloride | 186826-86-8 | Fourth-generation fluoroquinolone antibacterial | — | Docs on request |
| Isavuconazonium Sulfate | 946075-13-4 | Broad-spectrum systemic antifungal | — | Docs on request |
| Mefloquine Hydrochloride | 51773-92-3 | Antimalarial | — | Docs on request |
Targeted kinase & pathway inhibitors
| API | CAS No. | Therapeutic Application | Standard / Grade | Documentation |
|---|---|---|---|---|
| Palbociclib | 571190-30-2 | CDK4/6 inhibitor (breast cancer) | — | Docs on request |
| Ribociclib Succinate | 1374639-75-4 | CDK4/6 inhibitor (breast cancer) | — | Docs on request |
| Abemaciclib | 1231929-97-7 | CDK4/6 inhibitor (breast cancer) | — | Docs on request |
| Venetoclax | 1257044-40-8 | BCL-2 inhibitor (haematological malignancy) | — | Docs on request |
| Niraparib Tosylate | 1038915-73-9 | PARP inhibitor (ovarian cancer) | — | Docs on request |
| Axitinib | 319460-85-0 | VEGFR tyrosine-kinase inhibitor (RCC) | — | Docs on request |
| Lenvatinib Mesilate | 857890-39-2 | Multi-kinase inhibitor (thyroid, HCC) | — | Docs on request |
| Sorafenib Tosylate | 475207-59-1 | Multi-kinase inhibitor (HCC, RCC) | — | Docs on request |
| Regorafenib | 755037-03-7 | Multi-kinase inhibitor (colorectal cancer) | — | Docs on request |
| Alectinib Hydrochloride | 1256589-74-8 | ALK inhibitor (NSCLC) | — | Docs on request |
| Darolutamide | 1297538-32-9 | Androgen-receptor inhibitor (prostate cancer) | — | Docs on request |
| Relugolix | 737789-87-6 | GnRH-receptor antagonist (prostate cancer) | — | Docs on request |
| Eltrombopag Olamine | 496775-62-3 | Thrombopoietin-receptor agonist | — | Docs on request |
JAK inhibitors & immunomodulators
| API | CAS No. | Therapeutic Application | Standard / Grade | Documentation |
|---|---|---|---|---|
| Upadacitinib | 1310726-60-3 | JAK inhibitor (rheumatoid arthritis, IBD) | — | Docs on request |
| Baricitinib | 1187594-09-7 | JAK inhibitor (rheumatoid arthritis) | — | Docs on request |
| Tofacitinib Citrate | 540737-29-9 | JAK inhibitor (rheumatoid arthritis) | — | Docs on request |
| Ruxolitinib Phosphate | 1092939-17-7 | JAK1/2 inhibitor (myelofibrosis) | — | Docs on request |
CFTR modulators, CGRP, urology
| API | CAS No. | Therapeutic Application | Standard / Grade | Documentation |
|---|---|---|---|---|
| Tadalafil | 171596-29-5 | PDE5 inhibitor (ED, BPH, PAH) | — | Docs on request |
| Solifenacin | 242478-37-1 | Muscarinic antagonist (overactive bladder) | — | Docs on request |
| Rimegepant Sulfate | 1374024-48-2 | CGRP-receptor antagonist (migraine) | — | Docs on request |
| Ivacaftor | 873054-44-5 | CFTR potentiator (cystic fibrosis) | — | Docs on request |
| Tezacaftor | 1152311-62-0 | CFTR corrector (cystic fibrosis) | — | Docs on request |
| Lumacaftor | 936727-05-8 | CFTR corrector (cystic fibrosis) | — | Docs on request |
| Elexacaftor | 2216712-66-0 | CFTR corrector (cystic fibrosis) | — | Docs on request |
GLP-1 & specialty peptides
| API | CAS No. | Therapeutic Application | Standard / Grade | Documentation |
|---|---|---|---|---|
| Semaglutide | 910463-68-2 | GLP-1 agonist (type-2 diabetes, weight management) | — | Docs on request |
| Tirzepatide | 2023788-19-2 | GIP/GLP-1 co-agonist (diabetes, weight management) | — | Docs on request |
| Liraglutide | 204656-20-2 | GLP-1 agonist (diabetes, weight management) | — | Docs on request |
| Exenatide | 141732-76-5 | GLP-1 agonist (type-2 diabetes) | — | Docs on request |
| Octreotide Acetate | 83150-76-9 | Somatostatin analogue (acromegaly, NET) | — | Docs on request |
| Lanreotide | 108736-35-2 | Somatostatin analogue (acromegaly, NET) | — | Docs on request |
| Teriparatide Acetate | 52232-67-4 | PTH analogue (osteoporosis) | — | Docs on request |
| Abaloparatide Acetate | 247062-33-5 | PTHrP analogue (osteoporosis) | — | Docs on request |
| Bivalirudin | 128270-60-0 | Direct thrombin inhibitor (anticoagulant) | — | Docs on request |
| Eptifibatide | 188627-80-7 | GP IIb/IIIa antagonist (antiplatelet) | — | Docs on request |
| Terlipressin Acetate | 14636-12-5 | Vasopressin analogue (hepatorenal syndrome) | — | Docs on request |
| Ganirelix Acetate | 123246-29-7 | GnRH antagonist (assisted reproduction) | — | Docs on request |
| Icatibant Acetate | 138614-30-9 | Bradykinin B2 antagonist (angioedema) | — | Docs on request |
| Etelcalcetide | 1262780-97-1 | Calcimimetic (secondary hyperparathyroidism) | — | Docs on request |
| Linaclotide | 851199-59-2 | GC-C agonist (IBS-C, chronic constipation) | — | Docs on request |
| Atosiban Acetate | 90779-69-4 | Oxytocin antagonist (preterm labour) | — | Docs on request |
| Carbetocin Acetate | 37025-55-1 | Oxytocin analogue (postpartum haemorrhage) | — | Docs on request |
| Thymosin Alpha-1 | 62304-98-7 | Immunomodulator | — | Docs on request |
| Ziconotide Acetate | 107452-89-1 | N-type calcium-channel blocker (chronic pain) | — | Docs on request |
Ph.Eur./USP pharmaceutical grade
| API | CAS No. | Therapeutic Application | Standard / Grade | Documentation |
|---|---|---|---|---|
| Glycine | 56-40-6 | — | Ph. Eur. / USP | Docs on request |
| L-Alanine | 56-41-7 | — | Ph. Eur. / USP | Docs on request |
| L-Aspartic Acid | 56-84-8 | — | Ph. Eur. / USP | Docs on request |
| L-Glutamic Acid | 56-86-0 | — | Ph. Eur. / USP | Docs on request |
| L-Isoleucine | 73-32-5 | — | Ph. Eur. / USP | Docs on request |
| L-Leucine | 61-90-5 | — | Ph. Eur. / USP | Docs on request |
| L-Lysine Hydrochloride | 657-27-2 | — | Ph. Eur. / USP | Docs on request |
| L-Lysine Acetate | 57282-49-2 | — | Ph. Eur. / USP | Docs on request |
| L-Methionine | 63-68-3 | — | Ph. Eur. / USP | Docs on request |
| L-Phenylalanine | 63-91-2 | — | Ph. Eur. / USP | Docs on request |
| L-Serine | 56-45-1 | — | Ph. Eur. / USP | Docs on request |
| L-Threonine | 72-19-5 | — | Ph. Eur. / USP | Docs on request |
| L-Tryptophan | 73-22-3 | — | Ph. Eur. / USP | Docs on request |
| L-Tyrosine | 60-18-4 | — | Ph. Eur. / USP | Docs on request |
Anti-ageing & regenerative actives
| API | CAS No. | Therapeutic Application | Standard / Grade | Documentation |
|---|---|---|---|---|
| GHK-Cu (Tripeptide-1 Copper) | 89030-95-5 | Anti-ageing skin-conditioning peptide | — | Docs on request |
| Polydeoxyribonucleotide (PDRN) | 100403-24-5 | Tissue-regeneration activator | — | Docs on request |
| L-(+)-Ergothioneine | 497-30-3 | Antioxidant anti-ageing active | — | Docs on request |
| β-Nicotinamide Mononucleotide (NMN) | 1094-61-7 | NAD+ precursor / anti-ageing | — | Docs on request |
| β-Nicotinamide Adenine Dinucleotide (NAD) | 53-84-9 | Cellular-energy anti-ageing active | — | Docs on request |
| Nicotinamide Riboside Chloride (NRC) | 23111-00-4 | NAD+ precursor | — | Docs on request |
| Nonapeptide-1 | 158563-45-2 | Skin-brightening peptide | — | Docs on request |
| Palmitoyl Tripeptide-5 | 623172-56-5 | Anti-ageing peptide | — | Docs on request |
| Acetyl Hexapeptide-8 (Argireline) | 616204-22-9 | Expression-line peptide | — | Docs on request |
Regulatory and technical documentation is assessed product by product and confirmed against the intended market, dosage form and customer project before supply.
Final status, validity, manufacturing site coverage and regulatory scope must be verified during project qualification. Availability is subject to project qualification, applicable regulation, intellectual property, destination territory, documentation and commercial availability.